An observational study in Thrombosis and Venous Catheterization, sponsored by Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-11.
Sponsored by Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Observational
The aim is to determine the prevalence of catheter-related thrombosis (CRT) in hospitalized patients carrying PICC, FICC, CICC, and midline catheters through a multicenter, standardized prevalence study. To achieve this, a cross-sectional study with prospective data collection will be conducted, including, through consecutive sampling to minimize selection bias, all hospitalized patients over 18 years of age from both general wards and critical care units who have had one of these catheters in place for at least 7 days. During data collection, an ultrasound examination of the catheter insertion site will be performed in order to rule out the presence of thrombotic complications.
The study will be conducted across the following centers: Complejo Hospitalario Universitario Nuestra Señora de Candelaria, Hospital del Mar, Hospital Sant Joan de Déu-Althaia, Hospital Universitari Joan XXIII, Hospital Universitario de Navarra, Hospital Universitario Doctor Josep Trueta, Hospital Universitario Donostia, Hospital Universitario Mutua Terrassa, Hospital Universitario Son Espases, Policlínica Gipuzkoa, and Hospital de Navarra. Participation will include hospital institutions with an Infusion and Vascular Access Unit (IVAU) that has institutionally recognized expertise in the detection of catheter-related thrombosis (CRT).
Exclusion Criteria:
Overall prevalence of catheter-related thrombosis
Number of patients with CRT / total number of patients evaluated) × 100
Time frame: From the beginning of the cutoff to the end of the cutoff at 4 weeks
Symptomatic CRT
(Number of CRT cases with ≥1 clinical sign / total number of CRT cases) × 100
Time frame: From the beginning of the cutoff to the end of the cutoff at 4 weeks
Asymptomatic CRT
(Number of CRT cases without clinical signs / total number of CRT cases) × 100
Time frame: From the beginning of the cutoff to the end of the cutoff at 4 weeks
Superficial CRT
Number of superficial CRT cases / total number of CRT cases) × 100
Time frame: From the beginning of the cutoff to the end of the cutoff at 4 weeks
Deep CRT
Number of deep CRT cases / total number of CRT cases) × 100
Time frame: From the beginning of the cutoff to the end of the cutoff at 4 weeks
Prevalence by responsible service
(Number of CRT cases in each service category / total number of patients evaluated in that service) × 100
Time frame: From the beginning of the cutoff to the end of the cutoff at 4 weeks
Time from implantation to CRT diagnosis
Mean, SD, median, and IQR (interquartile range) of elapsed days
Time frame: From the beginning of the cutoff to the end of the cutoff at 4 weeks
Distribution by implanting operator
Number of CRT cases by implanting operator / total number of CRT cases × 100
Time frame: From the beginning of the cutoff to the end of the cutoff at 4 weeks
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta